stockrowRevvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.
- Revenue
- +4.29%
- EPS
- +2.17%
- Free cash flow
- +27.0%
- Total debt
- −18.1%
Quarter to September 2026, against a year earlier
Follow RVTY
Alert me
Revvity Inc. (RVTY) Shares outstanding
Revvity Inc.'s shares outstanding at the end of fiscal 2025 was $116.6M, down 5.07% from $122.8M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $111.8M. Over the past ten years it has ranged from $110.3M (fiscal 2016) to $126.4M (fiscal 2022); the current reading is higher than 64% of that period. Revvity Inc. ranks 15th of 49 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $116.6M | (5.07%) |
| FY2024 | $122.8M | (1.59%) |
| FY2023 | $124.8M | (1.28%) |
| FY2022 | $126.4M | 8.36% |
| FY2021 | $116.7M | 4.09% |
| FY2020 | $112.1M | 0.52% |
| FY2019 | $111.5M | (0.03%) |
| FY2018 | $111.5M | 0.61% |
| FY2017 | $110.9M | 0.49% |
| FY2016 | $110.3M | (2.65%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $111.8M | 0.18% |
| Jun 2026 | $111.6M | (0.22%) |
| Mar 2026 | $111.9M | (4.05%) |
| Dec 2025 | $116.6M | 0.98% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| QGEN QIAGEN N.V. compare | $207.8M |
| ILMN Illumina, Inc. compare | $154.0M |
| GH Guardant Health, Inc. compare | $134.4M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| RVTY Revvity Inc. | $111.8M |
| LH Labcorp Holdings Inc. compare | $81.6M |
| ICLR ICON PLC compare | $77.4M |
| CRL Charles River Laboratories International, Inc. compare | $48.6M |
| MEDP Medpace Holdings, Inc. compare | $28.4M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on RVTY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement